CTOs on the Move


 
AllMed Healthcare Management is a utilization management and independent review organization providing comprehensive nurse and physician review solutions to payer and provider organizations nationwide. Our clients include leading health plans, medical management organizations, TPAs, disability carriers, hospital groups and ambulatory surgery centers. Services are deployed through PeerPoint, AllMed`s state-of-the-art medical review portal.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.allmedmd.com
  • 111 SouthWest Fifth Avenue Suite 1400
    Portland, OR USA 97204
  • Phone: 800.400.9916

Executives

Name Title Contact Details
Jeff Keating
Chief Technology Officer Profile

Similar Companies

OneSpaWorld

Worldwide provider and innovator in the fields of wellness, beauty, rejuvenation and transformation across the globe at sea on cruise ships and on land.

Corizon

America Service Group Inc. (ASG) through its subsidiaries Prison Health Services, Inc. (PHS), EMSA Limited Partnership (EMSA), and Correctional Health Services, LLC (CHS), contracts to provide and/or administer managed healthcare services to over 120

MEDO USA

MEDO USA, Inc. is a Hanover Park, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Leeway Inc

Leeway Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in New Haven, CT. To find more information about Leeway Inc, please visit www.leeway.net

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.